Arca biopharma announces first quarter 2022 financial results

Westminster, colo., may 02, 2022 (globe newswire) -- arca biopharma, inc. (nasdaq: abio), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported first quarter 2022 financial results and provided a corporate update.
ABIO Ratings Summary
ABIO Quant Ranking